Microbiota and microbiotal medicine: Where we are now and what’s next?

The 9th ISM Annual Meeting will take place from the 19th to the 21st of October at Sorbonne University in Paris, France and Online. More than 300 participants from 25 different countries will be attending in person and online, and more than 86 communications will be presented this year.

Dr. Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France, stated: “After 2 years, we will be back in person in Paris, with more diversity of topics which may explain the complexity of our microbiota”.

Dr. Edeas thinks that we are still at the beginning in our exploration and we probably need to desiccate more the mechanism behind microbiota efficacy such as: extracellular vesicles and exosomes and their impact on microbiota communication and microbiota-host relationship, along with their potential implication in disease. Further exploration of the role of microbiota and its metabolites on iron metabolism should be highlighted.

Topics which Dr. Edeas thinks can be strongly explored in the future are:

1. Olfactory receptors;
2. Brain and behaviour;
3. Ageing & longevity;
4. Artificial intelligence and algorithms

Reference of Dr. Marvin Edeas’s talk: Microbiota medicine: towards clinical revolution - BMC Journal of Translational Medicine

Targeting Microbiota 2022 will highlight many new topics: Oral microbiota, vaginal microbiota, skin microbiota, metabolites, microbiota biofilms, retinal disorders, respiratory infections, arterial thrombosis, ischemic stroke, ageing, circadian system, depression, FMT, multi-omics, gene editing, precision medicine, cancer immunotherapy, mineral water, Mediterranean diet, weight loss...

Abstract Submission

• Short Oral Presentation submission deadline: September 30
• Poster Presentation submission deadline: October 10

More details on abstract submission. 

Registration

We remind you of the early bird registration deadline: August 30.

You can choose whether to register for in-person or online participation. Registration details.

About the ISM 2022 Speakers:

Peter C. Konturek, President of ISM, Teaching Hospital of the University of Jena, Germany – FMT 2022: Reorganization and Perspective Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France – Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?

Cristina Giaroni, University of Insubria, Italy – Microbiota and Drug Metabolism: Towards a Personalized Medicine

Christoph Reinhardt, University Mainz, Germany – Role of the Gut Microbiota in Arterial Thrombosis

Gerd Birkenmeier, University of Leipzig, Germany – May the Microbiota of the Long-Lived Naked Mole-Rat Affect Human Health?

Bertrand Routy, University of Montreal Hospital, Canada – Targeting Microbiota to Increase Cancer Immunotherapy Efficacy

Lei Dai, Shenzhen Institutes of Advanced Technology, China – Understanding the Heterogeneity of Host-associated Microbial Communities

Fermin I. Milagro, University of Navarra, Spain – Gut Microbiota-Derived Extracellular Vesicles on Obesity, Diabetes and Metabolism

François Leulier, Université de Lyon, France – Microbial and Nutritional Influence on Endocrine Control of Growth

Annalisa Terranegra, Sidra Medical and Research Center, Qatar – Precision Nutrition to Modulate Gut Microbiota in Reproductive Health and Pregnancy

Andrés Moya, University of València, Spain – Exploring a Healthy Human Gut Microbiota in a Mediterranean Cohort

Nathan Price, Thorne HealthTech, USA – Interpreting Microbiomes Via Multi-omics for Precision Health

Nicolas Barnich, Université Clermont Auvergne, France – Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota

Stephen Lindemann, Purdue University, USA – Manipulating Fiber Polysaccharide Structure to Alter Targeting to Gut Microbiota

Carmen González-Bosch, Universitat de València, Spain – Short-chain Fatty Acids as Modulators of Redox Signaling in Health and Disease

Frank Scheer, Harvard Medical School, USA – Proof-of-Principle Demonstration of Endogenous Circadian System and Circadian Misalignment Effects on Human Oral Microbiota

Pierre Déchelotte, Rouen Normandy University, France – The Probiotic Strain H. alvei HA4597 for Weight Loss

André Schmidt, University of Basel, Switzerland – Probiotics and FMT as Add-On Therapies for Depression

Xin Xu, Sichuan University, China – Oral Microbial Dysbiosis and Oral Diseases

Claire A. Woodall, University of Bristol, United Kingdom – Microbial Biomarkers to Predict Respiratory Infection

Matteo Serino, CRCN INSERM, France – Host-Microbes Mechanisms during E. coli Infections and Diet-induced Dysmetabolism

Maria Cecilia Giron, University of Padova, Italy – Cancer Therapy and Microbiota

Jarosław Biliński, Medical University of Warsaw, Poland – Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent

Benoit Chassaing, Institut Cochin, France – Host / Microbiota Interaction at the Mucosal Surface – Importance of a No Man’s Land !

Jean-Paul Motta, Institute of Digestive Health Research, France – Interactions Between Epithelial Proteases and Gut Microbiota Biofilms During Intestinal Disease

Miquel Lledós, Biomedical Research Institute Sant Pau, Spain – Influence of the Gut Microbiome in Ischemic Stroke Risk and Ischemic Stroke Outcome

Emrah Altindis, Biology Department Boston College, USA – A Gut Commensal, Parabacteroides distasonis, and Type 1 Diabetes Onset

Nahla Mansour, National Reseacrh Center, Egypt – Gene Editing and Microbiome Therapy

Gary Ventolini, Texas Tech University Health Sciences Center, USA – Vaginal Microbiota and Dysbiosis: Recent Advances and Perspective

Dimitra Skondra, University of Chicago, USA – Gut Microbiome and Retinal Disorders: Recent Advances and Perspectives

Sebastian Granica, Medical University of Warsaw, Poland – Interactions of Skin Microbiota with Chosen Plant Extracts and Natural Products More about the speakers and their talks.

About the International Society of Microbiota (ISM):

ISM was born in 2013 after the transformation of the Task Force Mitochondria-Microbiota to a larger group gathering all actors and experts working in the field of microbiota. The idea is to bring a new level of thinking and understanding of microbiota science out of the classical existing point of view. The science of gut and microbiota is a dynamic field, with a huge evolution and affected by multi factors. ISM will bring this new dynamic point of view to accelerate the credible translation of this science into real benefit for the consumer. ISM also encourages the communication and interaction among researchers, physicians, nutritionists, industrials, food technology and strategic marketing managers through a global microbiota network, especially during its annual world meeting.

More about ISM’s Annual meeting.  

---

---